Deep vein thrombosis landmark trials in prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 10: Line 10:
==RECORD 4==
==RECORD 4==


==MAGELLAN==
==Medically Ill Patients==
===MAGELLAN===


==ADOPT==
===ADOPT===


==References==
==References==

Revision as of 02:17, 20 June 2012

Deep Vein Thrombosis Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Deep vein thrombosis from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Approach

Assessment of Clinical Probability and Risk Scores

Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Venography

CT

MRI

Other Imaging Findings

Treatment

Treatment Approach

Medical Therapy

IVC Filter

Invasive Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Special Scenario

Upper extremity DVT

Recurrence

Pregnancy

Trials

Landmark Trials

Case Studies

Case #1

Deep vein thrombosis landmark trials in prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Deep vein thrombosis landmark trials in prevention

CDC on Deep vein thrombosis landmark trials in prevention

Deep vein thrombosis landmark trials in prevention in the news

Blogs on Deep vein thrombosis landmark trials in prevention

Directions to Hospitals Treating Deep vein thrombosis

Risk calculators and risk factors for Deep vein thrombosis landmark trials in prevention

Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Justine Cadet

RECORD 1

RECORD 2

RECORD 3

RECORD 4

Medically Ill Patients

MAGELLAN

ADOPT

References

Template:WH Template:WS